Additionally, a study found that the calretinin and mesothelin concentrations in MM cases appeared to increase mostly in the year before clinical diagnosis, suggesting they could be used as screening biomarkers in asbestos-exposed subjects [30]. This evidence concerns the gene CALB2 and Miyoshi myopathy.